🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Content Removal

Based on the social media company, the platform has removed violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.

After moments of entering one community, a vendor posted contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may expose patients to possibly significant medical dangers”.